We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Panel Finds End of Life a Struggle for Most

By HospiMedica staff writers
Posted on 21 Jan 2005
A panel convened to explore the end of life has found that, despite research progress, some aspects of the stage remain poorly understood and for many people, noncontinuity of care and poor communications among patients, doctors, and family members make this period a struggle.

The panel, convened by the U.S. More...
National Institutes of Health (NIH, Bethesda, MD, USA), called for the rapid development of research to improve the understanding of what works and what does not work in different groups of patients, and for enhanced resources to deliver quality care to patients and their families at the end of life. The panel also concluded that current Medicare hospice benefits limit the availability of the full range of interventions needed by many people at the end of life. For example, the eligibility requirement is a prognosis of six months or less to death, which raises problems. So does the forced selection of either skilled nursing or hospice care for patients entering nursing homes from hospitals, and the limits placed on certain therapies such as radiation, which may help manage symptoms.

The panel concluded that communication among patients, families, and providers is crucial to high-quality end-of-life care. Future studies, said the panel members, should recruit under-represented populations. Also, new networks of end-of-life researchers should be created and also well-defined cohorts of patients to facilitate the design of studies.

"We can begin by refining and agreeing upon our definitions of ‘end of life,' ‘palliative care,' and ‘hospice'--the terms have been used inconsistently and often interchangeably, which hinders not just the research enterprise but also effective communication between providers and patients as well,” said panel chair Margaret M. Heitkemper, Ph.D., R.N., professor and chair of the department of biobehavioral nursing and health systems at the University of Washington School of Nursing in Seattle (WA, USA).




Related Links:
National Institutes of Health

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.